TLT.V - Theralase Technologies Inc.

TSXV - TSXV Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/201412/31/2013
Total Revenue1,918.8931,945.2461,380.6041,203.62
Cost of Revenue796.569629.607459.323404.54
Gross Profit1,122.3241,315.639921.281799.08
Operating Expenses
Research Development1,867.6213,029.3691,455.301527.233
Selling General and Administrative4,161.3863,538.6822,046.9591,375.691
Non Recurring----
Others----
Total Operating Expenses6,825.5767,197.6583,961.5832,307.464
Operating Income or Loss-4,906.683-5,252.412-2,580.979-1,103.844
Income from Continuing Operations
Total Other Income/Expenses Net-14.56544.268-6.563-48.365
Earnings Before Interest and Taxes-4,906.683-5,252.412-2,580.979-1,103.844
Interest Expense-0.198-0.795-19.538-42.765
Income Before Tax-4,921.248-5,208.144-2,587.542-1,152.209
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-4,921.248-5,208.144-2,587.542-1,152.209
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-4,921.248-5,208.144-2,587.542-1,152.209
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-4,921.248-5,208.144-2,587.542-1,152.209